Teleflex Incorporated (NYSE:TFX) Receives Consensus Recommendation of “Hold” from Analysts

Teleflex Incorporated (NYSE:TFX) has earned an average rating of “Hold” from the ten research firms that are covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $146.00.

A number of research firms have recently issued reports on TFX. Royal Bank Of Canada raised Teleflex from a “sector perform” rating to an “outperform” rating and increased their price target for the stock from $135.00 to $155.00 in a research report on Friday, May 8th. Wells Fargo & Company upped their price objective on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research note on Friday, May 8th. Piper Sandler upgraded shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $140.00 to $160.00 in a report on Monday, June 8th. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, Truist Financial restated a “hold” rating and issued a $143.00 price target (up from $135.00) on shares of Teleflex in a report on Monday, May 11th.

Hedge Funds Weigh In On Teleflex

Several institutional investors and hedge funds have recently added to or reduced their stakes in TFX. Banque Cantonale Vaudoise boosted its stake in Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares in the last quarter. V Square Quantitative Management LLC acquired a new position in shares of Teleflex during the fourth quarter worth $37,000. UMB Bank n.a. lifted its holdings in shares of Teleflex by 57.1% during the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after purchasing an additional 113 shares during the last quarter. Sound Income Strategies LLC purchased a new stake in shares of Teleflex during the 4th quarter valued at $45,000. Finally, Kestra Advisory Services LLC acquired a new stake in shares of Teleflex in the 4th quarter worth $45,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Teleflex stock opened at $129.57 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The stock has a market cap of $5.74 billion, a price-to-earnings ratio of -5.68, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82. The firm has a 50-day moving average of $130.03 and a two-hundred day moving average of $119.67. Teleflex has a 1 year low of $100.18 and a 1 year high of $139.67.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.18. The firm had revenue of $548.30 million during the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company’s revenue was up 32.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, research analysts forecast that Teleflex will post 6.7 earnings per share for the current year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, May 25th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, May 22nd. Teleflex’s payout ratio is presently -5.96%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.